Anzeige
Mehr »
Login
Mittwoch, 23.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
KI-Energiekrise: Wie dieser Small Cap die nukleare Zukunft des Silicon Valley befeuern könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DQ1D | ISIN: US2936681095 | Ticker-Symbol:
NASDAQ
23.10.24
19:40 Uhr
31,900 US-Dollar
0,000
0,00 %
1-Jahres-Chart
ENTERPRISE BANCORP INC Chart 1 Jahr
5-Tage-Chart
ENTERPRISE BANCORP INC 5-Tage-Chart
GlobeNewswire (Europe)
170 Leser
Artikel bewerten:
(1)

Enterprise Bancorp Inc: Enterprise Bank Announces CEO Retirement and Successor Appointment

  • CEO John "Jack" P. Clancy to retire after distinguished 35-year career, with Enterprise, including more than 17 years as CEO
  • Enterprise Chief Banking Officer, Steven R. Larochelle, named CEO

LOWELL, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Enterprise Bancorp, Inc. (NASDAQ: EBTC) and Enterprise Bank today announced the retirement of Chief Executive Officer John "Jack" P. Clancy Jr., a position he has held since 2007. Mr. Clancy, named an honorary director of the company by its Board of Directors, will serve as an executive advisor. Succeeding him as CEO is Steven R. Larochelle, Chief Banking Officer of Enterprise Bank.

Mr. Clancy has served Enterprise Bank since its founding in 1989, starting as the chief financial officer where he was instrumental in the successful launch of the Bank. During Mr. Clancy's 17-year tenure as CEO, Enterprise Bank has grown from 14 branches to 27, while total bank assets grew from $980 million in 2006 to $4.6 billion as of March 2024. In his role as an Executive Advisor, Mr. Clancy will assist with the CEO transition.

"Jack has been the backbone of the Enterprise family for 35 years and mere words cannot express how much we appreciate his dedicated service. He is highly respected within the Bank, our community, and the banking industry in New England. It's to Jack's credit that Enterprise Bank was named one of the best places to work for 12 consecutive years under his leadership. Jack has more than earned retirement and time with his family, but we appreciate that he has agreed to ease the transition to a new CEO leadership by offering his advice and counsel," said George L. Duncan, Executive Chairman of the Board and Founder of Enterprise Bank.

A 40-year veteran of the banking industry, Mr. Larochelle has been with Enterprise for over 27 years, most recently as Chief Banking Officer. During his tenure with Enterprise, Mr. Larochelle has handled a wide range of responsibilities for the bank in the areas of commercial lending, cash management, wealth management, mortgage services and branch operations. Mr. Larochelle is a great champion of the Enterprise Bank culture, which takes pride in its strong relationships with its customers and communities. Mr. Larochelle has been deeply committed to the communities served by Enterprise Bank. He currently serves as the Chairman of the Board of Directors for D'Youville Life & Wellness Community.

Chairman George L. Duncan added, "We have developed a deep, talented leadership team and have worked hard to ensure succession across the organization to plan for leadership members' retirements. It is our pleasure to appoint Steven Larochelle as CEO. He steps into the role with a wealth of experience. He has earned the respect and admiration of his Enterprise colleagues and banking peers. He is the right person to lead us forward."

"I am honored and grateful to the Board of Directors to be afforded this opportunity to serve and am committed to a smooth transition for our team members, customers, community partners and shareholders," said Larochelle.

Enterprise Bancorp, Inc. is a Massachusetts corporation that conducts substantially all its operations through Enterprise Bank and Trust Company, commonly referred to as Enterprise Bank, and has reported 138 consecutive profitable quarters. Enterprise Bank is principally engaged in the business of attracting deposits from the general public and investing in commercial loans and investment securities. Through Enterprise Bank and its subsidiaries, the Company offers a range of commercial, residential and consumer loan products, deposit products and cash management services, electronic and digital banking options, as well as wealth management, and trust services. The Company's headquarters and Enterprise Bank's main office are located at 222 Merrimack Street in Lowell, Massachusetts. The Company's primary market area is the Northern Middlesex, Northern Essex, and Northern Worcester counties of Massachusetts and the Southern Hillsborough and Southern Rockingham counties in New Hampshire. Enterprise Bank has 27 full-service branches located in the Massachusetts communities of Acton, Andover, Billerica (2), Chelmsford (2), Dracut, Fitchburg, Lawrence, Leominster, Lexington, Lowell (2), Methuen, North Andover, Tewksbury (2), Tyngsborough and Westford and in the New Hampshire communities of Derry, Hudson, Londonderry, Nashua (2), Pelham, Salem, and Windham.

Contact Information: Matthew Coggins, Chief Marketing & Communications Officer. Matthew.Coggins@ebtc.com


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.